Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.20.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2020
Oct. 28, 2020
Document Information Line Items    
Entity Registrant Name Lantern Pharma Inc.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   6,217,577
Amendment Flag false  
Entity Central Index Key 0001763950  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Entity File Number 001-39318  
Entity Incorporation, State or Country Code TX  
Entity Interactive Data Current Yes